Testing effectiveness (Phase 2)Study completedNCT07281105
What this trial is testing
EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study
Who this might be right for
Neuropsychiatric Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE)Cognitive Impairment
Evergreen Therapeutics, Inc. 131